QUIDEL CORPORATION (NASDAQ:QDEL) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02.
|
Item 5.02
|
Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Current Report on Form 8-K reporting that Jack W. Schuler, 76,
informed the Board of Directors (the Board) of the Company that
he would not seek reelection to the Board at the 2017 Annual
Meeting of Shareholders that is scheduled to be held on May 16,
2017 (the Annual Meeting) and would retire from the Board
effective as of the date of the Annual Meeting. Subsequently, the
Nominating and Corporate Governance Committee and the Board
discussed with Mr. Schuler his ability and willingness to stand
for reelection, and on March 23, 2017 the Board nominated Mr.
Schuler to stand for reelection at the Annual Meeting. Mr.
Schuler has agreed to stand for reelection and no longer plans to
retire from the Board effective as of the date of the Annual
Meeting. Mr. Schuler has served on the Board since 2006.
About QUIDEL CORPORATION (NASDAQ:QDEL)
Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company’s diagnostic testing solutions primarily include applications in infectious diseases, women’s health and gastrointestinal diseases. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics and wellness screening centers. It markets its products in the United States through a network of national and regional distributors and a direct sales force. Internationally, it sells and markets primarily through distributor arrangements. Its diagnostic solutions are used in the detection and diagnosis of many critical diseases and other medical conditions, including autoimmune diseases, bone health and thyroid diseases. It provides diagnostic testing solutions under various brand names, including Quidel, QuickVue+ and Thyretain. QUIDEL CORPORATION (NASDAQ:QDEL) Recent Trading Information
QUIDEL CORPORATION (NASDAQ:QDEL) closed its last trading session up +0.32 at 22.16 with 129,824 shares trading hands.
